An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway
Strategies to direct drugs specifically to cancer cells have been increasingly explored, and significant progress has been made toward such targeted therapy. For example, drugs have been conjugated into tumor-targeting antibodies to enable delivery directly to tumor cells. Aptamers are an attractive...
Main Authors: | Xirui Song, Haixiang Yu, Cynthia Sullenger, Bethany Powell Gray, Amy Yan, Linsley Kelly, Bruce Sullenger |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/15/8/2301 |
Similar Items
-
An Aptamer for Broad Cancer Targeting and Therapy
by: Bethany Powell Gray, et al.
Published: (2020-10-01) -
Two Interconvertible Folds Modulate the Activity of a DNA Aptamer Against Transferrin Receptor
by: David Porciani, et al.
Published: (2014-01-01) -
Targeted Delivery of Auristatin-Modified Toxins to Pancreatic Cancer Using Aptamers
by: Christina Kratschmer, et al.
Published: (2018-03-01) -
Aptamers in Bordeaux, 24–25 June 2016
by: Jean-Jacques Toulmé, et al.
Published: (2017-01-01) -
Rapid molecular imaging of active thrombi in vivo using aptamer-antidote probes
by: Bethany Powell Gray, et al.
Published: (2023-03-01)